Healthcare Triangle, Inc.
HCTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $11,696 | $33,203 | $45,886 | $35,270 |
| % Growth | -64.8% | -27.6% | 30.1% | – |
| Cost of Goods Sold | $8,806 | $26,426 | $34,591 | $24,748 |
| Gross Profit | $2,890 | $6,777 | $11,295 | $10,521 |
| % Margin | 24.7% | 20.4% | 24.6% | 29.8% |
| R&D Expenses | $429 | $799 | $5,953 | $5,257 |
| G&A Expenses | $3,950 | $5,424 | $5,575 | $4,440 |
| SG&A Expenses | $6,153 | $10,094 | $12,383 | $9,201 |
| Sales & Mktg Exp. | $2,203 | $4,670 | $6,808 | $4,761 |
| Other Operating Expenses | $1,059 | $7,232 | $3,374 | $1,422 |
| Operating Expenses | $7,641 | $18,125 | $21,710 | $15,880 |
| Operating Income | -$4,751 | -$11,348 | -$10,416 | -$5,359 |
| % Margin | -40.6% | -34.2% | -22.7% | -15.2% |
| Other Income/Exp. Net | -$1,206 | -$956 | $869 | -$566 |
| Pre-Tax Income | -$5,957 | -$12,304 | -$9,547 | -$5,925 |
| Tax Expense | $12 | $35 | $63 | $24 |
| Net Income | -$5,969 | -$12,339 | -$9,610 | -$5,950 |
| % Margin | -51% | -37.2% | -20.9% | -16.9% |
| EPS | -281.584 | -517.527 | -966.643 | -503.453 |
| % Growth | 45.6% | 46.5% | -92% | – |
| EPS Diluted | -281.584 | -517.527 | -966.643 | -503.453 |
| Weighted Avg Shares Out | 21 | 17 | 15 | 12 |
| Weighted Avg Shares Out Dil | 21 | 17 | 15 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,213 | $968 | $212 | $567 |
| Depreciation & Amortization | $889 | $7,232 | $3,374 | $1,422 |
| EBITDA | -$3,855 | -$4,104 | -$5,961 | -$3,937 |
| % Margin | -33% | -12.4% | -13% | -11.2% |